Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells.

Hu P, Kinyamu HK, Wang L, Martin J, Archer TK, Teng C.

J Biol Chem. 2008 Mar 14;283(11):6752-63. doi: 10.1074/jbc.M705937200. Epub 2008 Jan 2.

3.

[Regulatory effect of 17beta-estradiol on expression of orphan nuclear receptor ERRalpha in endometrial carcinoma cell lines].

Gao M, Sun PM, Zhao D, Wang JL, Li XP, Wei LH.

Ai Zheng. 2006 May;25(5):538-42. Chinese.

PMID:
16687070
4.
5.

PGC-1alpha induces dynamic protein interactions on the ERRalpha gene multi-hormone response element nucleosome in kidney cells.

Wang L, Li Y, Hu P, Teng CT.

Biochem J. 2008 Dec 15;416(3):407-19. doi: 10.1042/BJ20081085.

PMID:
18673300
6.
7.

Estrogen-related receptor-alpha antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts.

Chisamore MJ, Wilkinson HA, Flores O, Chen JD.

Mol Cancer Ther. 2009 Mar;8(3):672-81. doi: 10.1158/1535-7163.MCT-08-1028. Epub 2009 Mar 10.

9.

Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.

Deblois G, Hall JA, Perry MC, Laganière J, Ghahremani M, Park M, Hallett M, Giguère V.

Cancer Res. 2009 Aug 1;69(15):6149-57. doi: 10.1158/0008-5472.CAN-09-1251. Epub 2009 Jul 21.

10.
11.

Activation of the estrogen-signaling pathway by p21(WAF1/CIP1) in estrogen receptor-negative breast cancer cells.

Chen X, Danes C, Lowe M, Herliczek TW, Keyomarsi K.

J Natl Cancer Inst. 2000 Sep 6;92(17):1403-13.

PMID:
10974076
12.

Characterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cells.

Chisamore MJ, Cunningham ME, Flores O, Wilkinson HA, Chen JD.

PLoS One. 2009 May 20;4(5):e5624. doi: 10.1371/journal.pone.0005624.

13.

Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer.

Thewes V, Simon R, Schroeter P, Schlotter M, Anzeneder T, Büttner R, Benes V, Sauter G, Burwinkel B, Nicholson RI, Sinn HP, Schneeweiss A, Deuschle U, Zapatka M, Heck S, Lichter P.

Cancer Res. 2015 Feb 15;75(4):720-31. doi: 10.1158/0008-5472.CAN-14-0652. Epub 2015 Feb 2.

15.
16.

Estrogen-related receptors-stimulated monoamine oxidase B promoter activity is down-regulated by estrogen receptors.

Zhang Z, Chen K, Shih JC, Teng CT.

Mol Endocrinol. 2006 Jul;20(7):1547-61. Epub 2006 Feb 16.

PMID:
16484337
17.

Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.

Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, Sun J, Weis K, Katzenellenbogen JA.

J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):279-85. Review.

PMID:
11162936
18.

An estrogen receptor alpha-dependent regulation of estrogen receptor-related receptor alpha in the proliferation of endometrial carcinoma cells.

Sun PM, Gao M, Wei LH, Mustea A, Wang JL, Könsgen D, Lichtenegger W, Sehouli J.

Int J Gynecol Cancer. 2006;16 Suppl 2:564-8.

PMID:
17010074
19.
20.

MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.

Lappano R, Santolla MF, Pupo M, Sinicropi MS, Caruso A, Rosano C, Maggiolini M.

Breast Cancer Res. 2012 Jan 17;14(1):R12.

Supplemental Content

Support Center